Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06342284 · ClinicalTrials.gov registry record
Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer
A clinical trial of Thoracic Cancer, sponsored by The New York Proton Center.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT06342284: Recruiting study of Thoracic Cancer, sponsored by The New York Proton Center.
NCT06342284 is a study of Thoracic Cancer that is actively recruiting participants, run by The New York Proton Center. The registered enrollment target is 40 participants, below the 346-participant average among 15 other Thoracic Cancer trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06342284, a study of Thoracic Cancer, is actively recruiting participants, sponsored by The New York Proton Center.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational study involving the collection of patient-generated health data using an Apple Watch, a home pulse oximeter, and a smartphone during a course of proton beam radiotherapy for lung cancer. The study period over which this information is collected will range from the day of study enrollment until two weeks after radiotherapy completion. Subjects will complete a short satisfaction survey at the end of the study period. Other information that is collected as part of routine care for this patient population will be extracted from subjects' medical records during the study period and afterwards.
Primary Outcome
Feasibility assessed based on the quantity of data collected from day of radiotherapy initiation to day of radiotherapy completion. The feasibility of physical activity data collection will be assessed based on usage information provided by the Apple Watch. Descriptive statistics to be used to report the distribution of average use times in the study cohort and the proportion of days subjects wear the Apple Watch for at least 8 hours. The feasibility of daily home pulse oximeter data collection
Conditions Studied
Interventions
- RADIATION Proton Beam Radiation with or without concurrent chemotherapy
Study Locations (1)
New York
- New York Proton Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-03-22 |
| Est. Completion | 2031-03-21 |
What NCT06342284 shows while recruiting
NCT06342284 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 346-participant average among 15 other Thoracic Cancer trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Thoracic Cancer appearing as the primary indexed condition, and to 1 intervention - of which Proton Beam Radiation with or without concurrent chemotherapy is the first listed.
NCT06342284 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06342284 about?
NCT06342284 is a clinical study titled "Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer". This is an observational study involving the collection of patient-generated health data using an Apple Watch, a home pulse oximeter, and a smartphone during a course of proton beam radiotherapy for lung cancer. The study period over which this information is collected will range from the day of stu...
What is the current status of trial NCT06342284?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2024-03-22. Estimated completion is 2031-03-21.
What conditions does trial NCT06342284 study?
This clinical trial studies the following conditions: Thoracic Cancer.
What interventions are being tested in trial NCT06342284?
The interventions under investigation include: Proton Beam Radiation with or without concurrent chemotherapy (RADIATION).
Who is sponsoring clinical trial NCT06342284?
This trial is sponsored by The New York Proton Center, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06342284 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thoracic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06342284's enrollment target sits among peer trials
40 11th of 15 higher than 4 of 15 other Thoracic Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Thoracic Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
RECRUITING · NA
-
Erector Spinae Block for Thoracic Surgery
RECRUITING · Phase 4
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
RECRUITING
-
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
RECRUITING · Phase 1
-
SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI